CNR Institutional Research Information System

ZECCA, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.878
NA - Nord America 1.998
SA - Sud America 577
EU - Europa 516
Continente sconosciuto - Info sul continente non disponibili 72
AF - Africa 46
OC - Oceania 3
Totale 6.090
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.892
SG - Singapore 1.175
CN - Cina 682
BR - Brasile 443
VN - Vietnam 341
HK - Hong Kong 265
FR - Francia 185
KR - Corea 123
IT - Italia 95
IN - India 74
CA - Canada 55
BD - Bangladesh 48
DE - Germania 46
AR - Argentina 43
JP - Giappone 43
GB - Regno Unito 34
FI - Finlandia 29
CO - Colombia 24
EC - Ecuador 23
ID - Indonesia 21
MX - Messico 21
NL - Olanda 20
VE - Venezuela 16
ES - Italia 15
IL - Israele 14
ZA - Sudafrica 13
MY - Malesia 12
RU - Federazione Russa 12
IQ - Iraq 10
LU - Lussemburgo 10
PY - Paraguay 9
UA - Ucraina 9
AE - Emirati Arabi Uniti 8
SA - Arabia Saudita 8
MA - Marocco 7
PE - Perù 7
AZ - Azerbaigian 6
KE - Kenya 6
TR - Turchia 6
AL - Albania 5
CL - Cile 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
IE - Irlanda 5
JO - Giordania 5
PA - Panama 5
PL - Polonia 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
AT - Austria 4
JM - Giamaica 4
NP - Nepal 4
PH - Filippine 4
PK - Pakistan 4
PT - Portogallo 4
RS - Serbia 4
SE - Svezia 4
TH - Thailandia 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
BE - Belgio 3
LB - Libano 3
NI - Nicaragua 3
UZ - Uzbekistan 3
BO - Bolivia 2
BS - Bahamas 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RO - Romania 2
SC - Seychelles 2
TW - Taiwan 2
YT - Mayotte 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BY - Bielorussia 1
CV - Capo Verde 1
DJ - Gibuti 1
DZ - Algeria 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
LV - Lettonia 1
MM - Myanmar 1
MT - Malta 1
NA - Namibia 1
NG - Nigeria 1
Totale 6.010
Salva come PNG Salva come JPEG
Città #
Singapore 686
Santa Clara 463
Hefei 311
Hong Kong 258
San Jose 242
Ashburn 135
Lauterbourg 127
Ho Chi Minh City 126
Seoul 122
Beijing 117
Hanoi 78
Los Angeles 41
Dallas 38
São Paulo 35
New York 28
Frankfurt am Main 24
Tokyo 24
Guangzhou 21
Helsinki 20
Mumbai 18
Buffalo 17
Brooklyn 16
Atlanta 15
Rio de Janeiro 15
Bengaluru 14
Houston 14
Milan 14
Minamishinagawa 14
Biên Hòa 11
Brasília 11
Da Nang 11
Belo Horizonte 10
Guayaquil 10
Luxembourg 10
Portsmouth 10
Boston 9
Chicago 9
Memphis 9
Orem 9
Queens 9
Rome 9
Brescia 8
Johannesburg 8
Philadelphia 8
Porto Alegre 8
Chennai 7
Curitiba 7
Dhaka 7
Düsseldorf 7
Haiphong 7
Las Vegas 7
Madrid 7
Quận Bình Thạnh 7
San Antonio 7
Toronto 7
Turku 7
Baku 6
Bogotá 6
Charlotte 6
Guarulhos 6
Manaus 6
Nairobi 6
Ribeirão Preto 6
Salvador 6
São Gonçalo 6
Taiyuan 6
Amman 5
Can Tho 5
Council Bluffs 5
Detroit 5
Duque de Caxias 5
Kuala Lumpur 5
Manchester 5
Milwaukee 5
Montreal 5
Naples 5
Nuremberg 5
Phoenix 5
San Francisco 5
Springfield 5
St Louis 5
The Bronx 5
Arese 4
Asunción 4
Birmingham 4
Buenos Aires 4
Calgary 4
Campinas 4
Cincinnati 4
Columbus 4
Denver 4
Dublin 4
Formosa 4
Goiânia 4
Hải Dương 4
Kolkata 4
La Paz 4
Lima 4
Miami 4
Montevideo 4
Totale 3.481
Salva come PNG Salva come JPEG
Nome #
The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. 227
Engineered nanoparticles. How brain friendly is this new guest? 106
New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals 97
Overexpression of Vesicular Monoamine Transporter-2 may Block Neurotoxic Metabolites from Cytosolic Dopamine: a Potential Neuroprotective Therapy for Parkinson's Disease 90
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease 88
Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease. 85
COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside 84
Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson's Disease 82
Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders 76
DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's disease 75
Aluminium in Alzheimer's disease: are we still at a crossroad? 74
Neuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells 74
Neuromelanins in brain aging and Parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative role 72
Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease 71
Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain 67
Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. 65
Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models 65
The neurobiology of human aggressive behavior: Neuroimaging, genetic, and neurochemical aspects 65
The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease 64
The role of neuromelanins in the oxidative stress of Parkinson's disease. 62
Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease 62
Neuromelanin of the Human Substantia Nigra: An Update 62
Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour 61
Highly Effective Protocol for Differentiation of Induced Pluripotent Stem Cells (iPS) into Melanin-Producing Cells 61
Dopamine, Oxidative Stress and Protein-Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases 58
Water-Soluble Melanin-Protein-Fe/Cu Conjugates Derived from Norepinephrine as Reliable Models for Neuromelanin of Human Brain Locus Coeruleus 57
Convenient Synthetic Method Of Putative Degradative Markers To Identify Various Catecholic Metabolites In Addition To Dopamine And Norepinephrine Incorporated In Neuromelanin. 56
Synthesis, Structure Characterization, and Evaluation in Microglia Cultures of Neuromelanin Analogues Suitable for Modeling Parkinson's Disease 56
Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease 56
Neuromelanin a chelator of iron and other metals in catecholaminergic neurons of substantia nigra and locus coeruleus. 54
The protective and toxic role of neuromelanins in brain aging and Parkinson's disease 52
Melanic Pigments in the Human brain 52
Synthetic models of neuromelanin with fibrillated protein in the core 51
Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease 51
A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease 51
Neuromelanins Isolated from Different Regions of the Human Brain Exhibit a Common Surface Photoionization Threshold 50
Contrast mechanisms associated with neuromelanin-MRI 50
Brain iron pathways and their relevance to Parkinson's disease. 49
The surface oxidation potential of human neuromelanin reveals a spherical architecture with a pheomelanin core and a eumelanin surface. 49
Neuromelanins in various regions of human brain are associated with native and oxidized isoprenoid lipids. 48
Iron, Myelin, and the Brain: Neuroimaging Meets Neurobiology 48
Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability. 48
Neuromelanin organelle pathways in aging and neurodegeneration of Parkinson's Disease 48
IRON, COPPER AND THEIR MOLECULES IN SUBSTANTIA NIGRA OF NORMAL SUBJECTS DURING AGING 47
The role of neuromelanin organelle pathways in parkinson's disease 46
NEUROMELANINS ACCUMULATE IN NEURONS DURING HUMAN BRAIN AGING AND BIND METALS 46
The Role of Iron in Neurodegeneration 46
Proteomic profile of neuromelanin and neuromelanin-containing organelles 46
Protective and toxic roles of dopamine in Parkinson's disease 45
Neuromelanin organelles pathways in brain aging and Parkinson's disease 44
The Neuromelanin of Human Substantia Nigra: Physiological and Pathogenic Aspects 44
Neuromelanin activates microglia and induces substantia nigra neuron death. A key mechanism of Parkinson's disease. 44
NEUROMELANIN ORGANELLES AND AUTOPHAGY IN BRAIN AGING 44
NEUROMELANIN ORGANELLES PATHWAYS AND NEURODEGENERATION IN PARKINSON'S DISEASE 43
Evidence for Dopamine Abnormalities in the Substantia Nigra in Cocaine Addiction Revealed by Neuromelanin-Sensitive MRI 43
Amyloid beta and neuromelanin - Toxic or protective molecules? The cellular context makes the difference. 43
Protective and neurotoxic role of neuromelanin in human brain 43
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease 42
Oleh Hornykiewicz, a giant in the understanding and treatment of Parkinson disease. 42
Neuromelanins in brain aging and Parkinson's disease. 42
Protective and toxic role of neuromelanin in brain aging and Parkinson's disease 40
The structure of neuromelanin as studied by chemical degradative methods 40
Molecular understanding of aluminum bioinorganic chemistry in relevance to the pathology of Alzheimer's disease 39
Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry 39
Melanin-protein fibrils conjugates as models to study neuromelanin structure and reactivity. 39
The neuromelanin of human substantia nigra and its interaction with metals 38
Application of Pump-Probe Imaging Towards Chemical and Structural Characterization of Neuromelanin. 38
Modeling Midbrain and Brainstem Neuromelanins to Characterize Metal Binding and Associated MRI Contrast in Parkinson's and Alzheimer's Diseases 38
Amyloid beta and neuromelanin - Toxic or protective molecules? The cellular context makes the difference. 38
Iron, brain ageing and neurodegenerative disorders. 37
α-Synuclein and Dopamine Metabolites DOPAL and DOPAC: A Pathway to New Synthetic Neuromelanin Models 36
Synthesis and structural characterization of soluble neuromelanin analogs provides important clues to its biosynthesis. 36
The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease 35
Combined biochemical separation and INAA for the determination of iron and other metals in Neuromelanin of human brain Substantia Nigra 35
In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage 35
Neuromelanin-sensitive MRI as a proxy-measure of dopamine function in neuropsychiatric illness. 35
Neuromelanin and metals in brain aging and neurodegeneration. 35
Biosynthetic pathway to neuromelanin and its aging process 34
Neuromelanin and metals in brain aging and neurodegeneration. 34
Mucuna pruriens: A new strategy for Parkinson's disease treatment in Africa. An update 33
Low iron, high ferritin and high neuromelanin in locus coeruleus neurons. A biochemical profile with relevance to neuronal vulnerability in parkinsonian syndromes. 33
Melanins and melanogenesis: from pigment cells to human health and technological applications 33
Neuromelanin inhibits CXCL10 expression in human astroglial cells 32
Iron, copper and their proteins in substantia nigra of human brain during aging. 32
Neuromelanins, oxidative stress and Parkinson's disease 31
Neuromelanin in human brain: protective and toxic role. 31
The role of neuromelanin and iron in brain aging and Parkinson's disease. 31
The role of neuromelanin in brain aging and neurodegeneration of Parkinson's disease 30
Effect on neurotransmitters and receptors in rat exposed to 50Hz electric and magnetic fields from conception to adult life 30
The application of the Neutron Activation Analysis for trace metals determination in human brain tissues and substantia nigra neuromelanin. 30
Iron and copper molecules in aging of human substantia nigra. Consequences for neurodegenerative processes. 29
Effect of prolonged exposure to 50 Hz electric and magnetic fields on neurotransmitters in rat brain 29
Neuromelanin in the human brain: protective and toxic role. 29
Neuromelanin activates microglia and induces substantia nigra neuron death. 29
Tracemetals, neuromelanin and neurodegeneration: An interesting area for research. 29
Norepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from the locus coeruleus 28
The relevance of low iron, high ferritin and high neuromelanin to neuronal vulnerability in parkinsonian syndromes. 28
Low iron, high ferritin and high neuromelanin in locus coeruleus neurons. A biochemical profile with relevance to neuronal vulnerability in parkinsonian syndromes 28
The role of neuromelanin in brain aging and Parkinson's disease. 28
MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration 28
Totale 5.001
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.340
article - articoli 12.765
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 445
Totale 34.550
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202446 0 0 0 0 0 0 0 0 1 0 44 1
2024/20251.948 3 9 167 71 432 47 23 139 53 65 484 455
2025/20263.299 185 426 287 482 590 136 467 171 147 182 110 116
2026/2027797 224 324 249 0 0 0 0 0 0 0 0 0
Totale 6.090